Search hospitals > Nevada > Reno
Sierra Eye Associates
Claim this profileReno, Nevada 89502
Global Leader in Age-Related Macular Degeneration
Global Leader in Macular Edema
Conducts research for Swelling
Conducts research for Diabetic Macular Edema
Conducts research for Atrophy
83 reported clinical trials
2 medical researchers
Summary
Sierra Eye Associates is a medical facility located in Reno, Nevada. This center is recognized for care of Age-Related Macular Degeneration, Macular Edema, Swelling, Diabetic Macular Edema, Atrophy and other specialties. Sierra Eye Associates is involved with conducting 83 clinical trials across 29 conditions. There are 2 research doctors associated with this hospital, such as Arshad Khanani, MD and Reno Site PI.Area of expertise
1Age-Related Macular Degeneration
Global LeaderStage I
Stage II
CFI positive
2Macular Edema
Global LeaderVEGF
Top PIs
Arshad Khanani, MDSierra Eye Associates5 years of reported clinical research
Studies Age-Related Macular Degeneration
Studies Diabetic Retinopathy
4 reported clinical trials
6 drugs studied
Reno Site PIReno Location3 years of reported clinical research
Studies Choroidal Detachment
Studies Retinal Disease
1 reported clinical trial
1 drug studied
Clinical Trials running at Sierra Eye Associates
Age-Related Macular Degeneration
Macular Edema
Swelling
Diabetic Macular Edema
Diabetic Retinopathy
Atrophy
Convergence Insufficiency
Retinal Disease
Cancer
Retinal Vein Occlusion
SUSVIMO
for Age-Related Macular Degeneration
This study will assess corneal endothelial cells in patients with neovascular age-related macular degeneration (nAMD) treated with Port Delivery System with ranibizumab (PDS) refilled every 24 weeks (Q24W)
Recruiting3 awards Phase 410 criteria
Axitinib Implant
for Age-Related Macular Degeneration
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects with Neovascular Age- Related Macular Degeneration
Recruiting2 awards Phase 31 criteria
RGX-314 Gene Therapy
for Age-Related Macular Degeneration
This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.
Recruiting2 awards Phase 32 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sierra Eye Associates?
Sierra Eye Associates is a medical facility located in Reno, Nevada. This center is recognized for care of Age-Related Macular Degeneration, Macular Edema, Swelling, Diabetic Macular Edema, Atrophy and other specialties. Sierra Eye Associates is involved with conducting 83 clinical trials across 29 conditions. There are 2 research doctors associated with this hospital, such as Arshad Khanani, MD and Reno Site PI.